Walgreen's Same-Store Sales Dive

pillsDrug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to the impact of generic drug sales replacing sales of higher-priced brand-name drugs. Total sales fell 3.9% from $6.09 billion last year to $5.85 billion.

Pharmacy sales in November fell 4.7%, and same-store pharmacy sales fell 8.8%. Pharmacy sales accounted for 63.2% of monthly sales.

Walgreen did not specifically indicate any impact from its now-resolved dispute with Express Scripts Inc. (NASDAQ: ESRX). During the nine-month fight with Express Scripts, Walgreen's lost millions of customers, and as much as 60% of the total could be gone permanently to competitor CVS Caremark Corp. (NYSE: CVS). Walgreen did say that prescriptions filled at comparable stores fell by 2.9% in November following a 1.8% drop in October.

Walgreen stock is up 2.45% this morning, at $35.12 in a 52-week range of $28.53 to $37.35, even though virtually every metric reported today was down. Even the number of flu shots administered is lower this year.

Paul Ausick

Filed under: 24/7 Wall St. Wire, Retail, Services Tagged: CVS, ESRX, WAG
Read Full Story


DJIA 24,715.09 1.11 0.00%
NASDAQ 7,354.34 -28.13 -0.38%
NIKKEI 225 23,042.54 112.18 0.49%
HANG SENG 31,424.03 376.12 1.21%
DAX 13,077.72 -36.89 -0.28%
USD (per EUR) 1.17 0.00 -0.15%
USD (per CHF) 1.00 0.00 0.18%
JPY (per USD) 111.06 0.18 0.16%
GBP (per USD) 1.34 0.00 -0.33%

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.